Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
![Foto de Instituto de Investigación Biomédica de A Coruña (INIBIC)](/img/noimage.png)
![Foto de Universidad de Salamanca](/img/noimage_org.png)
Universidad de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Universidad de Salamanca (61)
2024
-
Comparison of Clinical and Genetic Characteristics Between Younger and Older Lung Cancer Patients
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 88-94
-
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651
-
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours
International Journal of Molecular Sciences, Vol. 25, Núm. 3
-
Structure of graphene oxide-phospholipid monolayers: A grazing incidence X-ray diffraction and neutron and X-ray reflectivity study
Journal of Colloid and Interface Science, Vol. 655, pp. 664-675
2023
-
Addressing lung cancer screening eligibility in Spain using 2013 and 2021 US Preventive Service Task Force criteria: cross-sectional study
ERJ Open Research, Vol. 9, Núm. 6
-
Expert consensus on the use of systemic glucocorticoids for managing eosinophil-related diseases
Frontiers in immunology, Vol. 14, pp. 1310211
-
Expert opinion paper on the treatment of hemophilia a with emicizumab
Hematology (Amsterdam, Netherlands), Vol. 28, Núm. 1, pp. 2166334
-
Exploring High-Throughput Immunoassays for Biomarker Validation in Rheumatic Diseases in the Context of the Human Proteome Project
Journal of Proteome Research, Vol. 22, Núm. 4, pp. 1105-1115
-
Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review
Gastroenterologia y Hepatologia, Vol. 46, Núm. 5, pp. 382-396
-
Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project
Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1
-
Results of the compassionate program of inotuzumab ozogamicin for adult patients with relapsed or refractory acute lymphoblastic leukemia in Spain
European Journal of Haematology, Vol. 111, Núm. 3, pp. 485-490
2022
-
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy
European Journal of Heart Failure, Vol. 24, Núm. 7, pp. 1183-1196
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
-
Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis
Journal of Proteomics, Vol. 251
-
The impact of psychiatric pathology on the prognosis and survival of men with prostate cancer undergoing radical prostatectomy
Actas Urologicas Espanolas, Vol. 46, Núm. 10, pp. 646-652
2021
-
Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy
Journal of the American College of Cardiology, Vol. 78, Núm. 17, pp. 1682-1699
-
Cancer drug resistance induced by EMT: novel therapeutic strategies
Archives of Toxicology, Vol. 95, Núm. 7, pp. 2279-2297
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Blood Cancer Journal, Vol. 11, Núm. 5
2020
-
The value of the continuous genotyping of multi-drug resistant tuberculosis over 20 years in Spain
Scientific Reports, Vol. 10, Núm. 1